Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Tanzi

Showing results (561-570 of 579) with videos related to

Pageof 58
Sort By:
Genome Medicine|October 4, 2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioningAlexander Neumann, Olena Ohlei, Fahri Küçükali, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
Statins and genetic inhibition of the mevalonate pathway activate an ATF3-STMN2 regenerative programMatthew Nolan, Sandeep Aryal, I Sandra Ndayambaje, et al.
Nature Immunology|September 25, 2023
APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpointsZhuoran Yin, Neta Rosenzweig, Kilian L Kleemann, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
The New England Journal of Medicine|September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Plos Genetics|March 23, 2012
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene databaseChristina M Lill, Johannes T Roehr, Matthew B McQueen, et al.
Muscle & Nerve|October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis studyJean-Charles Lambert, Kristel Sleegers, Antonio González-Pérez, et al.
Nature Genetics|February 27, 2007
Mapping autism risk loci using genetic linkage and chromosomal rearrangements, Peter Szatmari, Andrew D Paterson, et al.
Nature Genetics|April 5, 2011
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's diseaseAdam C Naj, Gyungah Jun, Gary W Beecham, et al.
Pageof 58

Showing results (561-570 of 579) with videos related to

Sort By:
Pageof 58
Genome Medicine|October 4, 2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioningAlexander Neumann, Olena Ohlei, Fahri Küçükali, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
Statins and genetic inhibition of the mevalonate pathway activate an ATF3-STMN2 regenerative programMatthew Nolan, Sandeep Aryal, I Sandra Ndayambaje, et al.
Nature Immunology|September 25, 2023
APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpointsZhuoran Yin, Neta Rosenzweig, Kilian L Kleemann, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
The New England Journal of Medicine|September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Plos Genetics|March 23, 2012
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene databaseChristina M Lill, Johannes T Roehr, Matthew B McQueen, et al.
Muscle & Nerve|October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis studyJean-Charles Lambert, Kristel Sleegers, Antonio González-Pérez, et al.
Nature Genetics|February 27, 2007
Mapping autism risk loci using genetic linkage and chromosomal rearrangements, Peter Szatmari, Andrew D Paterson, et al.
Nature Genetics|April 5, 2011
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's diseaseAdam C Naj, Gyungah Jun, Gary W Beecham, et al.
Pageof 58